Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis

Laryngoscope

Volumn 110, Issue 3, 2000, Pages 374-381

  Villaret, Douglas B ^a   Wang, Tongtong ^b   Dillon, Davin ^b   Xu, Jiangchun ^b   Sivam, Dhileep ^b   Cheever, Martin A ^b   Reed, Steven G ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Gene markers; head and neck; microarray analysis; squamous cell carcinoma

Indexed keywords

CONNEXIN 26; GELATINASE A; KALININ; KERATIN; RNA; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC PROCEDURES; GENETIC SCREENING; HEAD CANCER; HUMAN; HUMAN TISSUE; MARKER GENE; NECK CANCER; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA;

14-3-3 PROTEINS; ADOLESCENT; ADULT; AGED; CANCER VACCINES; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CHEMOTACTIC FACTORS; CONNEXINS; DNA PROBES; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATINS; LASERS; LYMPHOKINES; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MOLECULAR BIOLOGY; PLAKOPHILINS; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; S100 PROTEINS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034056486     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-200003000-00008     Document Type: Article

References (22)

1. Collins SL. Controversies in multimodality therapy for head neck cancer: clinical and biological perspectives. In: Thawley SE, Panje WR, Batsakis JG, Lindberg RD, eds. Comprehensive Management of Head Neck Tumors. Philadelphia: WB Saunders, 1998.
2. Myers JN. Molecular pathogenesis of squamous cell carcinoma of the head neck. In: Suen JY, Myers EN, eds. Cancer of the Head Neck. Philadelphia: WB Saunders, 1996.
3. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genet Res 1996; 6:639-645.
4. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467-470.
5. Schena M, Shalon D, Heller R, et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996; 93:10614-10619.
6. Disis ML, Cheever MA. Oncogenic proteins as tumor antigens. Curr Opin Immunol 1996; 8:637-642.
7. Stoler A, Kopan R, Duvic M, Fuchs E. Use of monospecific antisera and cRNA probes to localize major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 1988; 107:427-446.
8. Klijanienko J, el-Naggar A, De Braud F, et al. Keratins 6, 13 and 19: differential expression in squamous cell carcinoma of the head and neck. Anal Quant Cytol Histol 1993; 15:335-340.
9. Bouden GT, Krieg P. Differential gene expression during multistage carcinogenesis. Environ Health Perspect 1991; 93:51-56.
10. Kainulainen T, Autio-Harmanen H, Oikarinen A, et al. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol 1997; 136:331-336.
11. Berndt A, Hyckel P, Konneker A, et al. Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation: clues from an in vitro invasion model. Invasion Metastasis 1997; 17:251-258.
12. Jamieson S, Going JJ, D'Arcy R, George WD. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumors. J Pathol 1998; 184:37-43.
13. Rivas MV, Jarvis ED, Morisaki S, et al. Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique. J Invest Dermatol 1997; 108:188-194.
14. Moll I, Kurzen H, Langbein L, Franke WW. The distribution of the desmosomal protein, plakophilin 1, in human skin and skin tumors. J Invest Dermatol 1997; 108:139-146.
15. Xia L, Stoll SW, Liebert M, et al. CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: evidence of a role in regenerative differentiation. Cancer Res 1997; 57:3055-3062.
16. Stoll SW, Zhao X, Elder JT. EGF stimulates transcription of CaN19 (S100A2) in HaCaT keratinocytes. J Invest Dermatol 1998; 111:1092-1097.
17. Hermeking H, Lengauer C, Polyak K, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1:3-11.
18. Repassy G, Forster-Horvath C, Juhasz A, et al. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res 1998; 4:14-21.
19. Petit AM, Rak J, Hung MC, et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997; 151:1523-1530.
20. Eisma RJ, Spiro JD, Kreutzer DL. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 1997; 174:513-517.
21. Salven P, Heikkila P, Anttonen A, et al. Vascular endothelial growth factor in squamous cell carcinoma: expression and prognostic significance. Mod Pathol 1997; 10:1128-1133.
22. Denhart BC, Guidi AJ, Tognazzi K, et al. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab Invest 1997; 77:659-664.